Lung Cancer Screening Research Program
Lung cancer usually does not cause any symptoms until it has reached an advanced stage. Tobacco is associated with 87 percent of all cases of cancer of the lung, trachea and bronchus. When lung cancer is diagnosed at an early stage (Stage IA ), and treated, the survival rate increases to more than 70 percent. The best way of increasing the chances of curing lung cancer is to find it early. The National Lung Screening Trial (NLST) showed that low-dose CT scans can detect lung cancers before they could be seen on regular X-rays.
You may be eligible for our Lung Cancer Screening Research Study if you meet the following criteria:
- Age: 45-74 years old
- Current smoker
- Former smoker who has quit within the past 15 years
- No history of cancer (except non-melanoma skin cancer) within the last five years
Monmouth Medical Center Leon Hess Cancer Center’s Lung Cancer Screening Program Joins I-ELCAP (International Early Lung Cancer Action Program)
Monmouth Medical Center is a member of I-ELCAP, a lung cancer screening research program committed to the advancement of knowledge for early diagnosis and treatment of lung cancer. Physician researchers are investigating to what extent low dose CT screening enhances the possibility of early detection of lung cancer and leads to higher cure rates.
For more information or to make an appointment, call the Lung Cancer Screening and Lung Nodule Program at 732-923-7966.